Gilead Sciences, Inc.
GILD
$114.10
-$0.335-0.29%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -91.53% | -97.86% | -80.78% | -91.31% | 23.37% |
| Total Depreciation and Amortization | 2.75% | 9.04% | 16.09% | 23.67% | 28.06% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 333.68% | 451.89% | 315.82% | 222.39% | -52.87% |
| Change in Net Operating Assets | 61.79% | -16.01% | -1,841.71% | -94.23% | -30.63% |
| Cash from Operations | 35.25% | 19.25% | -21.49% | -5.51% | -11.75% |
| Capital Expenditure | 10.60% | -7.26% | 2.39% | 1.53% | 19.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -320.14% | -362.33% | -211.85% | -201.36% | 35.89% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 462.50% | 721.40% | 571.51% | 1,835.16% | -994.92% |
| Cash from Investing | -52.27% | -106.53% | -44.76% | -64.09% | 8.15% |
| Total Debt Issued | 74.95% | -99.95% | -- | -- | -- |
| Total Debt Repaid | 12.44% | 12.76% | -310.10% | -125.00% | -50.00% |
| Issuance of Common Stock | 81.90% | -28.01% | -22.39% | -9.94% | -24.92% |
| Repurchase of Common Stock | -15.00% | 42.14% | 37.58% | 30.75% | 28.37% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.86% | -2.83% | -2.69% | -2.60% | -2.70% |
| Other Financing Activities | -1.08% | 0.37% | -11.91% | -20.83% | -60.69% |
| Cash from Financing | 33.01% | -21.72% | -12.19% | 16.46% | 20.78% |
| Foreign Exchange rate Adjustments | -170.18% | -45.26% | -93.10% | 181.25% | 190.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 200.00% | -- |
| Net Change in Cash | 480.39% | -166.50% | -403.83% | -134.06% | 809.46% |
